Coloplast A/S (CLPBY) Stock Analysis & Winston Score
Coloplast is a Danish medical device company that makes products for people with intimate health conditions — things like ostomy bags (for people who've had bowel surgery), catheters, wound care supplies, and continence products. Its customers are mostly patients, hospitals, and home care providers across the world. Coloplast is one of the largest companies globally focused specifically on these types of sensitive, chronic-care medical needs. The company earns money by selling its medical supplies directly and through healthcare distributors, with many patients relying on its products on a recurring, long-term basis — which creates steady, repeat revenue. Coloplast operates in over 40 countries, with strong positions in Europe and growing sales in North America and emerging markets. Its moat comes from deep clinical relationships, specialized product design, and the fact that patients rarely switch brands once they find something that works. The main risk is pricing pressure from government healthcare systems and competition from lower-cost rivals in key markets.
Winston Score: 57/100 — Good
A decent business — some strong pillars, some weaker.
- Quality: Good (16/30)
- Growth: Weak (2/20)
- Cash Flow: Exceptional (10/10)
- Stability: Good (5/10)
- Valuation: Exceptional (9/10)
- Ownership: Good (10/15)
Key Facts
Price: $6.80
Market Cap: $15.3B
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Exchange: Other OTC


